Michael Eifling, MD
Clinical Cardiac Electrophysiology · North Richland Hills, TXNPI 1295921989
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Abbott accounts for 70.6% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2023 at $100,408 and has fallen 70.9% since, to $29,192 in 2025. Among clinical cardiac electrophysiology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,025 payments — averaging $308.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$224K
- Johnson & Johnson$64K
- Medtronic$11K
- Atricure, Inc.$8K
- Biosense Webster, Inc.$7K
- Boston Scientific$2K
- plus $1K from 18 others
Across 26 payments — averaging $20,893 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$543K
What the payments were for
- Consulting fees$173,57255%
- Speaking & faculty fees$74,48024%
- Travel & lodging$36,69112%
- Food & beverage$31,92210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 393 | $223,629 |
| Johnson & Johnson | 67 | $63,529 |
| Medtronic(2 entities) | 124 | $11,180 |
| Atricure, Inc. | 22 | $8,074 |
| Biosense Webster, Inc. | 327 | $6,970 |
| Boston Scientific | 40 | $1,982 |
| E.r. Squibb & Sons, L.L.C. | 9 | $281 |
| Cardiofocus, Inc. | 2 | $176 |
| Pfizer | 9 | $165 |
| Sanofi-aventis U.S. LLC | 8 | $151 |
| Novartis | 6 | $96 |
| Bardy Diagnostics, Inc. | 3 | $74 |
| Biotronik Inc. | 3 | $63 |
| Abiomed | 1 | $42 |
| Boehringer Ingelheim | 2 | $41 |
| Cvrx, Inc. | 1 | $40 |
| Novo Nordisk | 1 | $31 |
| Daiichi Sankyo Inc. | 1 | $28 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| Altathera Pharmaceuticals LLC | 1 | $22 |
| Cardiva Medical, Inc. | 1 | $20 |
| Convatec Inc. | 1 | $18 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMPLATZER AMULET$188,906
- XARELTO$62,859
- AMPLATZER PICCOLO$7,752
- FREESTYLE LIBRE 3$7,310
- Assurity Pacemaker$5,583
- Carto 3$3,992
- Arctic Front$2,400
- AVEIR$2,002
- JETi All In One Non-Sterile Kit$1,895
- Fortify Assura, Ellipse ICD$1,855
- Micra$1,744
- Claria MRI$889
- Reveal LINQ$877
- Carto 3 System$761
- ATRICURE SYNERGY ABLATION SYSTEM$651
- AMPLATZER$633
- QUADRA ASSURA$505
- SelectSecure$451
- GENERAL - THERAPIES$444
- CareLink$321
How this compares
$316,665 in reported general payments places this provider in the 95th percentile of 233 clinical cardiac electrophysiology providers in Texas.
See all clinical cardiac electrophysiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 130 | $113,189 |
| XareltoRivaroxaban | 69 | $62,737 |
| Flecainide Acetate | 105 | $4,272 |
| Amiodarone Hcl | 199 | $3,487 |
| SotalolSotalol Hcl | 18 | $582 |
| Metoprolol Succinate | 55 | $505 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 14 | $334 |
| Potassium Chloride | 11 | $108 |
| Furosemide | 11 | $93 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $165 | $113,189130 claims |
| Johnson & JohnsonXarelto | $63,529 | $62,73769 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 233 clinical cardiac electrophysiology providers in Texas.
Other clinical cardiac electrophysiology in North Richland Hills
- Michael DelaughterBedford$1.6M
- Andrea NataleAustin$1.3M
- Jason ZagrodzkyAustin$961K
- Amin Al-AhmadAustin$771K
- Dale YooMcKinney$585K
- Rodney HortonAustin$553K
- Jose Cuellar SilvaWebster$502K
- Miguel ValderrabanoHouston$461K
- Theodore TakataFort Worth$396K
- Muhie Dean SabayonGalveston$361K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.